Resting-state glucose metabolism level is associated with the regional pattern of amyloid pathology in Alzheimer's disease.

TitleResting-state glucose metabolism level is associated with the regional pattern of amyloid pathology in Alzheimer's disease.
Publication TypeJournal Article
Year of Publication2011
AuthorsShin J, Tsui W, Li Y, Lee S-Y, Kim SJu, Cho S-J, Kim Y-B, de Leon MJ
JournalInt J Alzheimers Dis
Volume2011
Pagination759780
Date Published2011 Mar 17
ISSN2090-0252
Abstract

It has been suggested that glucose metabolism within the brain's default network is directly associated with-and may even cause-the amyloid pathology of Alzheimer's disease (AD). Here we performed 2-[(18)F]fluoro-2-deoxy-D-glucose (FDG) and [(11)C]-labeled Pittsburgh Compound B (PIB) positron emission tomography (PET) on cognitively normal elderly subjects and on AD patients and conducted quantitative regional analysis of FDG- and PIB-PET images using an automated region of interest technique. We confirmed that resting glucose metabolism within the posterior components of the brain's default network is high in normal elderly subjects and low in AD patients, which is partially in agreement with the regional pattern of PIB uptake within the default network of AD patients. However, in several regions outside the default network, glucose metabolism was high in normal elderly subjects but was not depressed in AD patients, who exhibited significantly increased PIB uptakes in these regions. In contrast, the level of resting glucose metabolism in the default network and in regions outside the default network in normal elderly subjects was significantly correlated with the level of regional PIB uptake in AD patients. These results are discussed with experimental evidence suggesting that beta amyloid production and amyloid precursor protein regulation are dependent on neuronal activity.

DOI10.4061/2011/759780
Alternate JournalInt J Alzheimers Dis
PubMed ID21461406
PubMed Central IDPMC3065040
Grant ListR01 AG022374 / AG / NIA NIH HHS / United States
R01 AG035137 / AG / NIA NIH HHS / United States
R21 AG032554 / AG / NIA NIH HHS / United States
R01 AG013616 / AG / NIA NIH HHS / United States
P30 AG008051 / AG / NIA NIH HHS / United States
RC2 AG036502 / AG / NIA NIH HHS / United States
R01 AG012101 / AG / NIA NIH HHS / United States
Related Institute: 
Brain Health Imaging Institute (BHII)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065